In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 151, Issue -, Pages 113124
Publisher
Elsevier BV
Online
2022-05-17
DOI
10.1016/j.biopha.2022.113124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin
- (2021) Thuy Van Lam van et al. ACS Medicinal Chemistry Letters
- Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2
- (2021) Hanjun Zhao et al. Nature Communications
- Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes
- (2021) Zelma Faisal et al. BIOMEDICINE & PHARMACOTHERAPY
- SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
- (2021) Michihito Sasaki et al. mBio
- In vitro interaction of potential antiviral TMPRSS2 inhibitors with human serum albumin and cytochrome P 450 isoenzymes
- (2021) Erzsébet Pászti-Gere et al. BIOMEDICINE & PHARMACOTHERAPY
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
- (2020) Ruochen Zang et al. Science Immunology
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
- (2020) Hanjun Zhao et al. Nature Communications
- Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
- (2020) Ya-Wen Cheng et al. Cell Reports
- Peptide and peptide-based inhibitors of SARS-CoV-2 entry
- (2020) Desiree Schütz et al. ADVANCED DRUG DELIVERY REVIEWS
- Interaction of Mycotoxin Alternariol with Serum Albumin
- (2019) Eszter Fliszár-Nyúl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics
- (2018) Zelma Faisal et al. Mycotoxin Research
- Interaction of Chrysin and Its Main Conjugated Metabolites Chrysin-7-Sulfate and Chrysin-7-Glucuronide with Serum Albumin
- (2018) Violetta Mohos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The biology and therapeutic targeting of the proprotein convertases
- (2012) Nabil G. Seidah et al. NATURE REVIEWS DRUG DISCOVERY
- Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics
- (2009) Gero L. Becker et al. JOURNAL OF MEDICINAL CHEMISTRY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now